Scienture Holdings Inc (SCNX)

Currency in USD
1.980
-0.030(-1.49%)
Closed·
After Hours
1.970-0.010(-0.51%)
·
SCNX Scorecard
Full Analysis
Quickly burning through cash
SCNX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.9202.093
52 wk Range
0.69011.734
Key Statistics
Prev. Close
2.01
Open
2.05
Day's Range
1.92-2.093
52 wk Range
0.69-11.734
Volume
79.22K
Average Volume (3m)
154.25K
1-Year Change
-84.28%
Book Value / Share
6.49
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SCNX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Scienture Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Scienture Holdings Inc Company Profile

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is based in Tampa, Florida.

Employees
17

Compare SCNX to Peers and Sector

Metrics to compare
SCNX
Peers
Sector
Relationship
P/E Ratio
−1.8x−1.3x−0.5x
PEG Ratio
0.01−0.010.00
Price/Book
0.3x1.3x2.6x
Price / LTM Sales
176.8x2.3x3.2x
Upside (Analyst Target)
-20.6%41.2%
Fair Value Upside
Unlock29.0%6.2%Unlock

Earnings

Latest Release
May 12, 2025
EPS / Forecast
-0.33 / --
Revenue / Forecast
10.26K / --
EPS Revisions
Last 90 days

SCNX Income Statement

People Also Watch

1.0600
GNS
+7.09%
2.330
RSLS
-2.92%
9.290
UMAC
-8.47%
2.540
PHIO
+0.40%
2.950
JSPR
-4.84%

FAQ

What Stock Exchange Does Scienture Holdings Trade On?

Scienture Holdings is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Scienture Holdings?

The stock symbol for Scienture Holdings is "SCNX."

What Is the Scienture Holdings Market Cap?

As of today, Scienture Holdings market cap is 25.71M.

What Is Scienture Holdings's Earnings Per Share (TTM)?

The Scienture Holdings EPS (TTM) is -2.68.

From a Technical Analysis Perspective, Is SCNX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Scienture Holdings Stock Split?

Scienture Holdings has split 4 times.

How Many Employees Does Scienture Holdings Have?

Scienture Holdings has 17 employees.

What is the current trading status of Scienture Holdings (SCNX)?

As of 29 Jul 2025, Scienture Holdings (SCNX) is trading at a price of 1.98, with a previous close of 2.01. The stock has fluctuated within a day range of 1.92 to 2.09, while its 52-week range spans from 0.69 to 11.73.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.